About David Zacks
Form D filings for ONL Therapeutics from 2014 to 2024 list David Zacks as executive officer.
David Zacks first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name David Zacks in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Zacks works with at each company, as listed on that company's latest Form D.
ONL Therapeutics, Inc. · Form D, Sep 16, 2024
DE
David Esposito
CEO & President, director
CC
Constance Chang
Executive officer
AF
Aaron Fletcher
Director
MS
Michal Silverberg
Director
BB
Bill Burns
Director
MN
Marian Nakada
Director